50% or greater reduction in seizure frequency · people with epilepsy
1 finding from 1 review
Reduction in seizure frequency: the difference in pre‐ and post‐treatment seizure rates · people with epilepsy
1 finding from 1 review
Improvement in quality of life: the difference in quality of life scores for participants surveyed before and after treatment · people with epilepsy
1 finding from 1 review
no estimate extracted
1 study · 7 participants
Very low
Word retrieval · adults with primary progressive aphasia (PPA)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall language abilities · adults with primary progressive aphasia (PPA)
1 finding from 1 review
Cognitive function · adults with primary progressive aphasia (PPA)
1 finding from 1 review
Quality of life · adults with primary progressive aphasia (PPA)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · adults with primary progressive aphasia (PPA)
1 finding from 1 review
Depression rating scale score · Post‐TBI Depression
It is very uncertain whether repetitive transcranial magnetic stimulation (rTMS) changes hamilton Rating Scale for Depression (HAM‐D); higher score means… compared with rTMS plus Tricyclic Anti‐depressant (very low certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · adults with chronic pain
1 finding from 1 review
Disability (0 to < 1 week postintervention) measured using self‐reported disability/pain interference scales · adults with chronic pain
1 finding from 1 review
QoL · adults with chronic pain
1 finding from 1 review
Fatigue · people with ALS/MND
1 finding from 1 review
Adverse events · people with ALS/MND
1 finding from 1 review
Safety of rTMS: Frequency of rTMS side effects (values are percentages) self‐reported questionnaire · participants with panic disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Changes to the ALSFRS‐R scores at 12 months · patients with the treatment of amyotrophic lateral sclerosis or motor neuron disease
1 finding from 1 review
Muscle strength · patients with the treatment of amyotrophic lateral sclerosis or motor neuron disease
1 finding from 1 review
Changes to FSS at 12 months · patients with the treatment of amyotrophic lateral sclerosis or motor neuron disease
1 finding from 1 review
Withdrawals due to adverse events · patients with the treatment of amyotrophic lateral sclerosis or motor neuron disease
1 finding from 1 review
panic symptoms · participants with panic disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found